Navigation Links
PharmaNet Extends Expiration Time in its Tender Offer and Consent Solicitation
Date:6/29/2011

of a consent to amend the related indenture. The Offer is made solely pursuant to the Offer to Purchase. The Offer is not being made to holders of Notes in any jurisdiction in which the making or acceptance thereof would not be in compliance with the securities, blue sky or other laws of such jurisdiction.

None of the Company, the Dealer Managers and Solicitation Agents, the Information Agent or any other person makes any recommendation as to whether holders of Notes should tender their Notes, and no one has been authorized to make such a recommendation.

Company Information and Forward Looking StatementsPharmaNet is a leading provider of integrated product development services and provides clinical development services, including consulting, Phase I and bioequivalency clinical studies, and Phase II, III and IV clinical development programs, to pharmaceutical, biotechnology, generic drug and medical device companies around the world.

This press release contains forward-looking statements which include, but are not limited to, any statement that may predict, forecast, indicate or imply future results, performance, achievements or events. Forward-looking statements are based upon management's current plans and beliefs or current estimates of future results or trends. These forward-looking statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties that may cause actual results to differ materially from trends, plans or expectations set forth in the forward-looking statements.

Given these risks and uncertainties, we urge you to read the tender offer materials completely and with the understanding that actual future results may be materially different from what we plan or expect. All of the forward-looking statements made in this press release, including statements related to the Offer, including the Expiration Time,
'/>"/>

SOURCE PharmaNet Development Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. PharmaNet Extends Consent Payment Deadline for Notes Tendered in Its Tender Offer and Consent Solicitation
2. PharmaNet Announces Tender Offer and Consent Solicitation
3. PharmaNet to Present More Than 20 Posters at the 2010 American Association of Pharmaceutical Scientists Annual Meeting
4. PharmaNet Development Group Experts to Share Insights at the 9th Annual Partnerships in Clinical Trials Conference in Vienna
5. PharmaNet Development Group Appoints Anthony Maida, Vice President, Clinical Research
6. Stephen Kasay Joins PharmaNet Development Group as Chief Information Officer
7. SEC Closes Investigation of PharmaNet Development Group and Recommends No Action
8. Christopher Brennan Joins PharmaNet Development Group as General Counsel
9. PharmaNet Development Group Provides Financial Update and Announces Geographic Expansion
10. PharmaNet Development Group Clinical Research Experts to Present at Global Professional Meetings in June
11. PharmaNet Development Group Gives Notice of Anticipated Fundamental Change and Merger to Holders of Its Convertible Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... Diego, CA (PRWEB) December 17, 2014 ... and activation agency and member of the Huntsworth Health ... Gonzales to its executive team. In her role, Gonzales ... , “We are incredibly honored to welcome a ... Agency Chief and CEO, Gaëtan Fraikin. “She is a ...
(Date:12/17/2014)... , Dec. 17, 2014   Synageva BioPharma ... company developing therapeutic products for rare disorders, announced today ... being held in San Francisco, CA. ... and Chief Executive Officer, will present on Monday, January ... The presentation will be webcast live and may be ...
(Date:12/15/2014)... Agritech Limited (NASDAQ GS: SEED) (" Origin ", or the ... China , today announced that the Company ... 30, 2014, before the market opens on Thursday, January 8, ... January 8, 2015, at 8:00 a.m. ET / 9:00 p.m. ... To participate in the call, please dial +1-888-346-8982 in ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 The ... million in 2013, and is expected to grow ... 2019. , Browse through the TOC of the ... industry trends and segments, with help of various ... The global DNA Microarray market consists of instrument, ...
Breaking Biology Technology:Audacity Welcomes Healthcare Communications Expert Jamie Gonzales as Senior Vice President of Client Services 2Origin Agritech Limited to Announce Fiscal 2014 Annual Financial Results on January 8th, 2015 2Origin Agritech Limited to Announce Fiscal 2014 Annual Financial Results on January 8th, 2015 3DNA Microarray Market Is Expected to Grow at a CAGR of 15.2% from 2014 to 2019 - A Report by MicroMarket Monitor 2DNA Microarray Market Is Expected to Grow at a CAGR of 15.2% from 2014 to 2019 - A Report by MicroMarket Monitor 3DNA Microarray Market Is Expected to Grow at a CAGR of 15.2% from 2014 to 2019 - A Report by MicroMarket Monitor 4
... In the recent issue of Nature , scientists from ... how they have managed for the first time to grow ... a simple surface-based chemical method. Graphene ribbons are considered to ... can be adjusted through width and edge shape. Transistors ...
... , July 21 ViroPharma Incorporated,s (Nasdaq: VPHM ) second quarter ... 2010 before the open of the U.S. financial markets. , ... The company will host a conference call and live audio webcast at ... ViroPharma management will discuss the 2010 second quarter financial results and other business. ...
... United Therapeutics Corporation (Nasdaq: UTHR ) announced today that it ... Wednesday, July 28, 2010 . , ... United Therapeutics will host a half-hour teleconference on Wednesday, ... teleconference is accessible by dialing 1-877-351-5881, with international callers dialing 1-970-315-0533.  A ...
Cached Biology Technology:Nanoribbons for graphene transistors 2Nanoribbons for graphene transistors 3ViroPharma to Release 2010 Second Quarter Financial Results on July 28, 2010 2
(Date:11/21/2014)... 2014 C-Labs LLC, a leading provider of ... (IoT), today announced the appointment of John Traynor ... a strategic advisor to the firm, Mr. Traynor will ... is based out of the C-Labs office in ... Chris Muench , Chief Executive Officer. Photo ...
(Date:11/18/2014)... Nov. 18, 2014   EyeLock Inc. , ... and MorphoTrust USA (Safran), a leading ... announced a strategic partnership to offer comprehensive biometric ... administration (MVA), airport screening and financial services markets. ... MorphoTrust serves consumers through a nationwide network of ...
(Date:11/7/2014)... associate professor, biomedical engineering, in the Grove School ... York, have identified a molecule that could lead ... aggressive forms of breast cancer. , Triple negative ... owing to aggressive proliferation and metastasis and a ... team, discovered the overexpression of intercellular adhesion molecule-1 ...
Breaking Biology News(10 mins):C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3
... scientists reported in today,s issue of the journal ... to produce insect-killing proteins isolated from the soil bacterium ... even to neighboring farmers who grow non-transgenic varieties of ... playing a critical role in addressing many of the ...
... study by researchers at Purdue University suggests that some ... function and continue playing even though they are impaired. ... of cognitive impairment," said Thomas Talavage, an expert in ... engineering and electrical and computer engineering and co-director of ...
... LA JOLLA, CA-For the second time in its 50-year ... and Public Service Medals. Gene expression pioneer Robert G. ... Salk Institute Medal for Research Excellence. Irwin M. Jacobs, ... the Salk Institute Medal for Public Service. ...
Cached Biology News:New study shows benefits of Bt corn to farmers 2Brain changes found in football players thought to be concussion-free 2Brain changes found in football players thought to be concussion-free 3Brain changes found in football players thought to be concussion-free 4Brain changes found in football players thought to be concussion-free 5Brain changes found in football players thought to be concussion-free 6Salk Institute Medals to be awarded to Robert Roeder and Irwin Jacobs 2Salk Institute Medals to be awarded to Robert Roeder and Irwin Jacobs 3
... tissues from mouse, rat, and human sources ... sectioned and mounted onto slides. After removing ... use in tissue RNA localization by in ... suitable for in situ hybridization using both ...
...
Quantibody Human Angiogenesis Array 1 (1 slide) Class: Quantitative Antibody Arrays Product Group: Antibody Array...
Immunochemistry 1 & 2...
Biology Products: